These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 323764)

  • 41. Serum 17 beta-estradiol and estrone levels in postmenopausal women with and without endometrial cancer.
    Judd HL; Lucas WE; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):272-8. PubMed ID: 950362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The source(s) of estrogen production in hirsute women with polycystic ovarian disease as determined by simultaneous adrenal and ovarian venous catheterization.
    Wajchenberg BL; Achando SS; Mathor MM; Czeresnia CE; Giannella Neto D; Kirschner MA
    Fertil Steril; 1988 Jan; 49(1):56-61. PubMed ID: 3121397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
    Nagamani M; Hannigan EV; Dillard EA; Van Dinh T
    J Clin Endocrinol Metab; 1986 Mar; 62(3):508-12. PubMed ID: 3944235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Massive extranglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy.
    Hemsell DL; Edman CD; Marks JF; Siiteri PK; MacDonald PC
    J Clin Invest; 1977 Aug; 60(2):455-64. PubMed ID: 874104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer.
    Reed MJ; Beranek PA; Ghilchik MW; James VH
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1395-400. PubMed ID: 3830220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.
    Steingold K; De Ziegler D; Cedars M; Meldrum DR; Lu JK; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid hormones and endometrial cancer.
    Siiteri PK
    Cancer Res; 1978 Nov; 38(11 Pt 2):4360-6. PubMed ID: 359136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Editorial: Cancer risk and estrogen use in the menopause.
    Ryan KJ
    N Engl J Med; 1975 Dec; 293(23):1199-200. PubMed ID: 1186792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aromatase in aging women.
    Bulun SE; Zeitoun K; Sasano H; Simpson ER
    Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endocrine factors in the etiology of endometrial carcinoma.
    Gimes G; Szarvas Z; Siklósi G
    Neoplasma; 1986; 33(3):393-7. PubMed ID: 2942790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The hormonal activity of the postmenopausal ovary.
    Vermeulen A
    J Clin Endocrinol Metab; 1976 Feb; 42(2):247-53. PubMed ID: 177438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ovarian production of estrogen in postmenopausal women with endometrial carcinoma].
    Donát J; Jirkalová V
    Cesk Gynekol; 1989 Jun; 54(5):356-60. PubMed ID: 2791004
    [No Abstract]   [Full Text] [Related]  

  • 55. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer.
    Judd HL; Davidson BJ; Frumar AM; Shamonki IM; Lagasse LD; Ballon SC
    Am J Obstet Gynecol; 1980 Apr; 136(7):859-71. PubMed ID: 7361834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
    Santen RJ; Santner S; Davis B; Veldhuis J; Samojlik E; Ruby E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1257-65. PubMed ID: 263348
    [No Abstract]   [Full Text] [Related]  

  • 57. The estrogen--cancer controversy.
    Greenblatt RB; Stoddard LD
    J Am Geriatr Soc; 1978 Jan; 26(1):1-8. PubMed ID: 618948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
    Samojlik E; Santen RJ; Kirschner MA; Ertel NH
    Cancer Res; 1982 Aug; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
    Geisler J; Haynes B; Anker G; Helle H; Ekse D; Dowsett M; Lønning PE
    J Steroid Biochem Mol Biol; 2005 Sep; 96(5):415-22. PubMed ID: 16168635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endometrial cancer and estrogen use. Report of a large case-control study.
    Antunes CM; Strolley PD; Rosenshein NB; Davies JL; Tonascia JA; Brown C; Burnett L; Rutledge A; Pokempner M; Garcia R
    N Engl J Med; 1979 Jan; 300(1):9-13. PubMed ID: 213722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.